Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 495-503, May 2006

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors☆

  • Elisa García-Garayoa

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 56 310 28 17; fax: +41 56 31 0 28 49.
    • ,
  • Veronique Maes

      Affiliations

    • Vrije Universiteit Brussel, Department of Organic Chemistry, B-1050 Brussel, Belgium
    • ,
  • Peter Bläuenstein

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
    • ,
  • Alain Blanc

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
    • ,
  • Alexander Hohn

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
    • ,
  • Dirk Tourwé

      Affiliations

    • Vrije Universiteit Brussel, Department of Organic Chemistry, B-1050 Brussel, Belgium
    • ,
  • P. August Schubiger

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland

Received 15 November 2005; received in revised form 10 January 2006; accepted 12 January 2006. published online 02 May 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Work partly funded by the Fund for Scientific Research-Flanders (Belgium), contract No. G.0036.04.

PII: S0969-8051(06)00012-6

doi:10.1016/j.nucmedbio.2006.01.007

Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 495-503, May 2006

Article Tools

* Image Usage & Resolution